冠状动脉化得分作为患有多发性骨髓瘤的年轻患者进行自主干细胞治疗的预后因素
Hans-Jonas Meyer1, Wolfram Pönisch2, Jan Borggrefe3
1Department of Diagnostic and Interventional Radiology, University of Leipzig, 04103, Leipzig, Germany. hans-jonas.meyer@medizin.uni-leipzig.de.
Cardio-oncology (London, England)
|April 24, 2025
概括
冠状动脉化 (CAC) 不能预测在接受干细胞治疗的多发性骨髓瘤患者的生存率. 这项研究发现,CAC对这一患者群体的整体存活率没有显著的影响.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 放射学 放射学是一门学科.
背景情况:
- 通过计算机断层扫描 (CT) 进行冠状动脉化 (CAC) 评分可以表明一般心血管风险.
- 多发性骨髓瘤 (MM) 是一种异质的血液性恶性瘤.
- 在接受干细胞移植的MM患者中,CAC的预后价值尚未得到充分确立.
研究的目的:
- 调查CAC对多发性骨髓瘤 (MM) 患者整体生存 (OS) 的影响.
- 为了确定CAC评分是否可以作为MM患者的预后标记.
主要方法:
- 对127名接受了外周血液干细胞移植 (2009-2019) 的MM患者进行了回顾性分析.
- 使用全身CT扫描评估的CAC得分和作为Agatston得分的替代品的Weston得分.
- 统计分析包括歧视分析和费舍尔的精确测试.
主要成果:
- 在非幸存者和幸存者之间的CAC得分没有显著差异 (平均1.2对2.0,p=0.13).
- CAC评分与整体存活率没有相关性 (HR 0.92,p=0.35).
- 在患有化和没有化的患者之间,死亡率没有统计学上显著的差异 (p=0.20).
结论:
- 通过CT定义的冠状动脉化不能预测接受自主干细胞治疗的年轻MM患者的生存率.
- 在这种异质的MM群体中,CT定义的心血管风险因素的影响似乎很小.
更多相关视频
11:30A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
1.9K
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
891
相关概念视频
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
